Why we disagree with the analysis of wenzel et al.

Infection Control and Hospital Epidemiology

Volumn 30, Issue 5, 2009, Pages 497-499

  Farr, Barry M ^a   Jarvis, William R ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b Jarvis and Jason Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTEREMIA; BLOODSTREAM INFECTION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; ENTEROCOCCUS; HEALTH CARE COST; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; SCREENING; CROSS INFECTION; ECONOMICS; HOSPITAL; METHODOLOGY; MICROBIOLOGY; NOTE; STANDARD; STAPHYLOCOCCUS INFECTION; UNITED STATES;

CROSS INFECTION; HOSPITALS; HUMANS; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 67649726847     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/597064     Document Type: Letter

References (12)

1. Wenzel RP, Bearman G, Edmond MB. Screening for MRSA: a flawed hospital infection control intervention. Infect Control Hosp Epidemiol2008; 29:1012-1018.
2. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-2732.
3. Datta R, Huang SS. Risk of infection and death due to methicillinresistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 2008; 47:176-181.
4. DiGiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160:976-981.
5. Byers KE, Farr BM. The impact of catheter-related bloodstream infections. In: O' Grady NP, Pittet D, eds. Catheter-Related Infections in the Critically Ill. Boston: Kluwer Academic Publishers; 2004:87-98.
6. Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital- wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006; 43:971-978.
7. Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002; 51:126-132.
8. Wenzel RP, Edmond MB. The evolving technology of venous access. N Engl J Med 1999; 340:48-50.
9. Rello J. Impact of nosocomial infections on outcome: myths and evidence. Infect Control Hosp Epidemiol 1999; 20:392-394.
10. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763-1771.
11. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982; 97:309-317.
12. Farr BM. Doing the right thing (and figuring out what that is). Infect Control Hosp Epidemiol 2006; 27:999-1003.